Drug Profile
Research programme: analgesics - Labopharm
Alternative Names: DDS-06ALatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Labopharm
- Developer Altus Formulation Inc
- Class Acetanilides
- Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in Canada (PO, Controlled release)
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 07 Oct 2011 Labopharm has been acquired by Paladin Labs